GlassScriptPhysician profile
Brian J Williams
NPI 1841300506
$5,072.48
in general payments reported to CMS, 2019-2025
38 companies · $508 in 2025
The $508 reported for 2025 was more than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $541 · 2020: $575 · 2021: $1,219 · 2022: $1,165 · 2023: $512 · 2024: $552 · 2025: $508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,572.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $743.03 | 2020-2024 | Skyrizi |
| Regeneron Healthcare Solutions, INC. | $557.72 | 2019-2025 | Dupixent, Libtayo |
| Janssen Biotech, INC. | $497.26 | 2019-2024 | Tremfya |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $458.06 | 2019-2025 | Siliq, Cabtreo, Jublia |
| Lilly USA, LLC | $371.33 | 2019-2024 | Olumiant, Taltz |
| Sun Pharmaceutical Industries INC. | $328.39 | 2019-2025 | |
| Ucb, INC. | $301.90 | 2020-2025 | Bimzelx |
| Leo Pharma INC. | $174.06 | 2019-2025 | Anzupgo |
| Mayne Pharma Commercial LLC | $168.04 | 2019-2023 | |
| Almirall LLC | $151.12 | 2019-2025 | Seysara, Klisyri |
| Genzyme Corporation | $148.62 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $108.05 | 2022-2025 | Ofev |
| Biofrontera INC. | $105.65 | 2019-2023 | Xepi, Bf-Rhodoled, Ameluz |
| Amgen INC. | $99.31 | 2019-2025 | Otezla, Otezla |
| Genentech USA, INC. | $99.30 | 2019-2021 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.